We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





Nano-Based Sensor Technologies Could Make It Possible to Detect COVID-19 at Any Disease Stage, Say Researchers

By LabMedica International staff writers
Posted on 02 Dec 2020
Print article
Image: Various diagnostic techniques can be used for sensing the RNA of SARS-CoV-2 (Photo courtesy of Saadet Alpdagtas and Elif Ilhan)
Image: Various diagnostic techniques can be used for sensing the RNA of SARS-CoV-2 (Photo courtesy of Saadet Alpdagtas and Elif Ilhan)
Despite various diagnostic techniques for COVID-19, no single test is available for the entire stage of the disease, although nano-based sensor technologies could make it possible to detect the attack at any stage of the disease, according to researchers.

Researchers at the Van Yuzuncu Yil University (Van, Turkey) along with their colleagues evaluated the available diagnostic techniques for COVID-19 and determined the key steps required for better testing moving forward. Laboratory tests that target the virus's genes - known as real-time reverse transcription-polymerase chain reaction assays - are currently the gold standard for testing. But according to the US Food and Drug Administration (FDA), these tests could give false negatives. These tests depend on the presence of antibodies, which may not have yet been developed in the early stages of infection. Since different antibodies appear at different stages, diagnostic tests must be chosen to target the appropriate immune response based on when an individual is believed to have been infected.

"There is not any available single test for the entire stage of the disease," said Oguzhan Gunduz, one of the researchers. "However, I think it may be possible to detect the attack at any stage of the disease with nano-based sensor technologies."

The researchers have emphasized point-of-care testing as an urgent objective. These types of tests would help detect the virus on site without the need for laboratory equipment or specialized personnel, eliminating or reducing the wait time between testing and obtaining results

"A quite sensitive test that can measure the existent tiny number of viral particles, or any parameter related to the particle - weight, structure, charge, diameter - can provide rapid and early diagnosis," said Gunduz.

When asked about the potential for a more comfortable testing method, Gunduz stressed that this depends on the sampling method and its sensitivity. A fingertip blood test or a saliva test could potentially be underway, though these have their own drawbacks.

"There are such tests, but they come up with accuracy and specificity issues," added Gunduz.

Related Links:
Van Yuzuncu Yil University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: A false color scanning election micrograph of lung cancer cells grown in culture (Photo courtesy of Anne Weston)

AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell

Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.